Last reviewed · How we verify
NCT04605783: P2
Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel
NA trial testing Travelan® in Diarrhea in 851 participants. Completed in 20 June 2025.
20 June 2025
Quick facts
| Lead sponsor | Henry M. Jackson Foundation for the Advancement of Military Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 851 |
| Start date | 27 May 2022 |
| Primary completion | 20 June 2025 |
| Estimated completion | 20 June 2025 |
| Sites | 6 locations across United Kingdom, United States |
Drugs / interventions tested
- Travelan®
- Placebo
Conditions studied
- Diarrhea — all drugs for Diarrhea →
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Who can join
Adults 18 to 70, any sex, with Diarrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Passive immunoprophylaxis is a class of dietary supplements that is lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate passive immunoprophylaxis (Travelan®) product compared with placebo, to assess the ability to maintain normal gut function during travel. The results of this clinical trial will be used to evaluate the use of a dietary supplement to maintain GH during deployment and travel and is not intended to support a marketing application of any dietary supplement as a drug or biological product for human use.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders.
Sasso JM, Ammar RM, Tenchov R, Lemmel S, et al · · 2023 · cited 100× · PMID 37156006 · DOI 10.1021/acschemneuro.3c00127
Verify or expand the search:
- PubMed search for NCT04605783
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diarrhea
Currently open trials in the same condition.
- NCT07285785 — Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea · Phase 4 · recruiting
- NCT07385196 — Defining Ileorectal Syndrome: a Prospective Observational Study · recruiting
- NCT07205926 — First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Yo · Phase 1 · recruiting
- NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting
- NCT06801067 — A Study of SER-155 to Treat Diarrhea in People on Immunotherapy · Phase 1 · recruiting
Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials
Trials by the same sponsor.
- NCT07223684 — TDAP in Burn Patients (Group 2) · not yet recruiting
- NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting
- NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
- NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
- NCT06855186 — Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04605783 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henry M. Jackson Foundation for the Advancement of Military Medicine
- Last refreshed: 17 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04605783.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing